New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva
Citations Over TimeTop 10% of 2015 papers
Abstract
Successful in vitro disease-recapitulation using patient-specific induced pluripotent stem cells (iPSCs) requires two fundamental technical issues: appropriate control cells and robust differentiation protocols. To investigate fibrodysplasia ossificans progressiva (FOP), a rare genetic disease leading to extraskeletal bone formation through endochondral ossification, gene-corrected (rescued) iPSC clones (resFOP-iPSC) were generated from patient-derived iPSC (FOP-iPSC) as genetically matched controls, and the stepwise induction method of mesenchymal stromal cells (iMSCs) through neural crest cell (NCC) lineage was used to recapitulate the disease phenotype. FOP-iMSCs possessing enhanced chondrogenic ability were transcriptionally distinguishable from resFOP-iMSCs and activated the SMAD1/5/8 and SMAD2/3 pathways at steady state. Using this method, we identified MMP1 and PAI1 as genes responsible for accelerating the chondrogenesis of FOP-iMSCs. These data indicate that iMSCs through NCC lineage are useful for investigating the molecular mechanism of FOP and corresponding drug discovery.
Related Papers
- → Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva(2009)40 cited
- → Pregnancy in fibrodysplasia ossificans progressiva(2011)10 cited
- → Fibrodysplasia ossificans progressiva in two half-sisters: Evidence for maternal mosaicism(1996)35 cited
- → Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva(2018)10 cited
- → The progress in the treatment of fibrodysplasia ossificans progressiva(2015)